Value of multi-glycan in the auxiliary diagnosis of dual-phenotype hepatocellular carcinoma

Huijuan FENG; Yu ZHANG; Chuanshang ZHUO; Chenjun HUANG; Meng FANG; Lijuan LIU

doi:10.3969/j.issn.1001-5256.2022.06.019

Volume 38 Issue 6

Jun. 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(6): 1317-1322

PDF( 3387 KB)

Value of multi-glycan in the auxiliary diagnosis of dual-phenotype hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2022.06.019

1.
Department of Clinical Laboratory, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China
2.
Department of Laboratory Medicine, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China

Research funding:

Sponsored by Fuzhou Health Technology Project (2019-S-wq19);

Startup Fund for Scientific Research, Fujian Medical University (2019QH1296);

Fujian Provincial Natural Science Foundation Projects (general) (2020J011169)

More Information

Corresponding author: LIU Lijuan, ljliu@126.com (ORCID:0000-0001-9809-0056)
Received Date: 2021-09-27
Accepted Date: 2021-12-23
Published Date: 2022-06-20

Abstract

Abstract

Objective To investigate the expression of multi-glycan in serum of patients with dual-phenotype hepatocellular (DPHCC) and its clinical significance. Methods Serum samples were collected from 65 patients with DPHCC, 80 patients with primary hepatocellular carcinoma (HCC), and 120 patients with liver cirrhosis (LC) who were treated in Mengchao Hepatobiliary Hospital of Fujian Medical University from June 2019 to December 2020. DNA sequencer-aided fluorophore-assisted carbohydrate electrophoresis was used to measure the expression of N-glycan in serum, The measurement data of normal distribution were compared by t-test between the two groups and analysis of variance between multiple groups; The measurement data with non normal distribution were compared by Mann-Whitney U test between the two groups and Kruskal-Wallis H test between multiple groups, the chi-square test was used for comparison of categorical data between groups.The logistic regression method was used to establish the common index model. The efficacy of AFP, PIVKA - Ⅱ, CEA, CA19-9 and multi glycan in the diagnosis of DPHCC was evaluated by receiver operating characteristic (ROC) curve, and the area under ROC curve (AUC) was compared by Z test. Results There was a significant difference in multi-glycan between the DPHCC group and the HCC group (P < 0.001), while there were no significant differences in AFP, PIVKA-Ⅱ, CEA, CA19-9, and SUM between the two groups (P=0.924, 0.084, 0.442, 0.924, and 0.206). Multi-glycan had an area under the ROC curve (AUC) of 0.775, which was significantly higher than that of AFP (0.507), PIVKA-Ⅱ (0.584), CEA (0.537), CA19-9 (0.505), and SUM (0.561), and multi-glycan had a sensitivity of 69.23%, which was increased compared with the other 5 items. There were significant differences in multi-glycan, AFP, PIVKA-Ⅱ, CA19-9, and SUM between the DPHCC group and the LC group (all P < 0.001), but there was no significant difference in CEA between the two groups (P=0.14). Multi-glycan had an AUC of 0.780, which was also higher than that of AFP (0.767), PIVKA-Ⅱ (0.743), CEA (0.566), CA19-9 (0.689), and SUM (0.713), and multi-glycan had a sensitivity of 89.23%, which was increased compared with the other five items. Conclusion Multi-glycan can be used as one of the indicators for the auxiliary diagnosis of DPHCC.
- Carcinoma, Hepatocellular,
- Multi-antenna of N-glycan,
- Diagnosis

FullText(HTML)

References(15)

References

[1]	ZHENG QL, FENG CY, LIAN YE, et al. Clinical and pathological analysis of 6 cases of diphenotypic hepatocellular carcinoma[J]. Chin J Pathol, 2020, 49(12): 1320-1322. DOI: 10.3760/cma.j.cn112151-20200319-00237. 郑巧灵, 冯昌银, 连渊娥, 等. 双表型肝细胞癌六例临床病理学分析[J]. 中华病理学杂志, 2020, 49(12): 1320-1322. DOI: 10.3760/cma.j.cn112151-20200319-00237.
[2]	WANG H, CONG WM. Research progress on clinicopathology in dual-phenotype hepatocellular carcinoma[J]. Chin J Clin Oncol, 2017, 44(12): 616-619. DOI: 10.3969/j.issn.1000-8179.2017.12.071. 王瀚, 丛文铭. 双表型肝细胞癌新亚型的临床病理学研究进展[J]. 中国肿瘤临床, 2017, 44(12): 616-619. DOI: 10.3969/j.issn.1000-8179.2017.12.071.
[3]	Chinese Society of Liver Cancer, Chinese Anti-Cancer Association, Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Pathology, Chinese Anti-Cancer Association, et al. Evidence-based practice guidelines for the standardized pathological diagnosis of primary liver cancer in China(2015 update)[J]. J Clin Hepatol, 2015, 31(6): 833-839. DOI: 10.3969/j.issn.1001-5256.2015.06.004. 中国抗癌协会肝癌专业委员会, 中华医学会肝病学分会肝癌学组, 中国抗癌协会病理专业委员会, 等. 原发性肝癌规范化病理诊断指南(2015年版)[J]. 临床肝胆病杂志, 2015, 31(6): 833-839. DOI: 10.3969/j.issn.1001-5256.2015.06.004.
[4]	FANG M, GAO CF. Glycosylation and biomarkers in primary liver cancer[J]. Chin J Lab Med, 2016, 39(2): 73-75. DOI: 10.3760/cma.j.issn.1009-9158.2016.02.001. 房萌, 高春芳. 糖基化与原发性肝癌标志物[J]. 中华检验医学杂志, 2016, 39(2): 73-75. DOI: 10.3760/cma.j.issn.1009-9158.2016.02.001.
[5]	HUANG C, FANG M, FENG H, et al. N-glycan fingerprint predicts alpha-fetoprotein negative hepatocellular carcinoma: A large-scale multicenter study[J]. Int J Cancer, 2021, 149(3): 717-727. DOI: 10.1002/ijc.33564.
[6]	HUANG C, LIU L, WANG H, et al. Serum N-glycan fingerprint nomogram predicts liver fibrosis: A multicenter study[J]. Clin Chem Lab Med, 2021, 59(6): 1087-1097. DOI: 10.1515/cclm-2020-1588.
[7]	National Health and Family Planning Commission of the People's Republic of China. Diagnosis, management, and treatment of hepatocellular carcinoma (V2017)[J]. J Clin Hepatol, 2017, 33(8): 1419-1431. DOI: 10.3969/j.issn.1001-5256.2017.08.003. 中华人民共和国国家卫生和计划生育委员会. 原发性肝癌诊疗规范(2017年版)[J]. 临床肝胆病杂志, 2017, 33(8): 1419-1431. DOI: 10.3969/j.issn.1001-5256.2017.08.003.
[8]	Bureau of Medical Administration, National Health Commission of the People's Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. J Clin Hepatol, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007. 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007.
[9]	Chinese Society of Infectious Diseases, Chinese Medical Association, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007. 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
[10]	GUAN W, GAO Z, HUANG C, et al. The diagnostic value of serum DSA-TRF in hepatocellular carcinoma[J]. Glycoconj J, 2020, 37(2): 231-240. DOI: 10.1007/s10719-019-09906-x.
[11]	LI T, MO C, QIN X, et al. Glycoprofiling of early gastric cancer using lectin microarray technology[J]. Clin Lab, 2018, 64(1): 153-161. DOI: 10.7754/Clin.Lab.2017.170814.
[12]	WANG Z, LIU H, YAN Y, et al. Integrated proteomic and N-Glycoproteomic analyses of human breast cancer[J]. J Proteome Res, 2020, 19(8): 3499-3509. DOI: 10.1021/acs.jproteome.0c00311.
[13]	TANAKA T, YONEYAMA T, NORO D, et al. Aberrant N-Glycosylation profile of serum immunoglobulins is a diagnostic biomarker of urothelial carcinomas[J]. Int J Mol Sci, 2017, 18(12): 2632. DOI: 10.3390/ijms18122632.
[14]	BEDNARSKA NG, WREN BW, WILLCOCKS SJ. The importance of the glycosylation of antimicrobial peptides: natural and synthetic approaches[J]. Drug Discov Today, 2017, 22(6): 919-926. DOI: 10.1016/j.drudis.2017.02.001.
[15]	MARTINEZ MR, DIAS TB, NATOV PS, et al. Stress-induced O-GlcNAcylation: An adaptive process of injured cells[J]. Biochem Soc Trans, 2017, 45(1): 237-249. DOI: 10.1042/BST20160153.

Relative Articles

[1]	Shuying MIAO, Jun YANG, Wenyan GUAN, Biao ZHANG, Lu HE, Zhiwen FAN. Role of circular RNA in the development, progression, diagnosis, and treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2023, 39(8): 1983-1991. doi: 10.3969/j.issn.1001-5256.2023.08.033
[2]	Tingting HE, Qingsheng LIANG, Liping WANG, Longxin LIANG, Xiaohan LI, Yanfei CUI, Jing JING, Zhaofang BAI, Man GONG, Ruilin WANG. Diagnostic values of integrated evidence chain, Roussel Uclaf Causality Assessment Method, and Structured Expert Opinion Process method for drug-induced liver injury[J]. Journal of Clinical Hepatology, 2022, 38(1): 141-147. doi: 10.3969/j.issn.1001-5256.2022.01.022
[3]	Xiaotong QIU, Zhengqi WU, Xuxiang XIA, Guoyue LYU. Lymphoepithelioma-like hepatocellular carcinoma: A case report[J]. Journal of Clinical Hepatology, 2022, 38(3): 634-635. doi: 10.3969/j.issn.1001-5256.2022.03.027
[4]	Renjie LU, Fangfang SUN, Jie DU, Lirong ZHAO. Hepatocellular carcinoma with bile duct tumor thrombus: A case report[J]. Journal of Clinical Hepatology, 2022, 38(8): 1872-1874. doi: 10.3969/j.issn.1001-5256.2022.08.028
[5]	Xi CAO, Yanling SUN, Cuiying CHEN, Yiwei XIAO, Kuanhui XIANG, Xueen LIU, Hui ZHUANG. Association between the alteration of serum N-glycan profile and the change of glycosyltransferase expression in liver tissue in patients with hepatitis B virus-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(6): 1336-1341. doi: 10.3969/j.issn.1001-5256.2021.06.024
[6]	Radiology of Infection Sub-branch, Radiology Branch, Chinese Medical Association, Committee on Radiology of Infection, Radiology Branch, Chinese Medical Doctor Association, Radiology Committee on Infectious and Inflammatory Disease, Chinese Research Hospital Association, Radiology of Infection Branch, Working and Treating Committee of HIV/AIDS and STD Association, Radiology of Infectious Disease Management Sub-branch, Infectious Disease Management Branch, Hospital Management Association in China, Beijing Imaging Diagnosis and Treatment Technology Innovation Alliance. Consensus on imaging techniques and diagnostic criteria for hepatitis B virus related early hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(4): 787-791. doi: 10.3969/j.issn.1001-5256.2021.04.013
[7]	Mingjun LIU, Yingjuan LIU, Gui YANG, Songmei LIU. Association of the expression of glucose-6-phosphate dehydrogenase with the prognosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(8): 1856-1860. doi: 10.3969/j.issn.1001-5256.2021.08.021
[8]	Xin CAI, Juanjuan CHEN, Dongling TANG, Ping'an ZHANG. Value of alpha-fetoprotein combined with gamma-glutamyl transpeptidase/aspartate aminotransferase ratio in diagnosis of HBV-associated hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(9): 2109-2112. doi: 10.3969/j.issn.1001-5256.2021.09.021
[9]	Chuanshang HUO, Huijuan FENG, Zhi YE, Ying LIN, Li CHEN, Fei PENG, Lijuan LIU. Value of serum autophagy-related protein 7 in diagnosis of HBV-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(10): 2327-2331. doi: 10.3969/j.issn.1001-5256.2021.10.014
[10]	Xichen LIU, Yiying WANG, Manman TONG, Junjie QIN. Biomarkers for the early diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(1): 176-179. doi: 10.3969/j.issn.1001-5256.2021.01.038
[11]	Tao WANG, Dongfeng CHEN. Clinical diagnosis and treatment of hepatocellular carcinoma: From guidelines to clinical practice[J]. Journal of Clinical Hepatology, 2021, 37(8): 1745-1747. doi: 10.3969/j.issn.1001-5256.2021.08.001
[12]	Huijun XIE, Nasot Rashed, Yong NING, Chuan GAO. Current status of research on circulating microRNAs as diagnostic markers for hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(2): 448-451. doi: 10.3969/j.issn.1001-5256.2021.02.042
[13]	Xin CAI, Juanjuan CHEN, Dongling TANG, Pingan ZHANG. Role of circular RNA in the development and progression of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(3): 695-698. doi: 10.3969/j.issn.1001-5256.2021.03.039
[14]	Shiyan YAN, Jiangao FAN. Diagnosis and treatment of hepatocellular carcinoma associated with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(8): 1748-1752. doi: 10.3969/j.issn.1001-5256.2021.08.002
[15]	Luo Qiong, Wang ChunMing, Liao HangYu, Chen KunLing, Pan MingXin. Value of the NDRG family in the diagnosis and prognostic evaluation of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(6): 1284-1288. doi: 10.3969/j.issn.1001-5256.2020.06.019
[16]	Guan GuiWen, Yao MingJie, Qian XiangJun, Zhai XiangWei, Yan XiaoTong, Zhao JingMin, Lu FengMin, Chen XiangMei. Value of combined measurement of alpha-fetoprotein and alpha-fetoprotein L3% in the diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(7): 1514-1519. doi: 10.3969/j.issn.1001-5256.2019.07.019
[17]	Li RuoKun, Yan FuHua, Li Ke. Value of Gd-EOB-DPTA in the diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(7): 1378-1381. doi: 10.3969/j.issn.1001-5256.2018.07.003
[18]	Wang ShiMei, Wu Xia, Kang Peng, Meng QingYang. Diagnostic value of H19 gene in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(11): 2203-2205. doi: 10.3969/j.issn.1001-5256.2016.11.046
[19]	Li Mi, Nie QingHe. The progress of Fibro Scan technique for diagnosis of hepatocellular carcinoma value[J]. Journal of Clinical Hepatology, 2015, 31(6): 969-973. doi: 10.3969/j.issn.1001-5256.2015.06.035
[20]	Jin Yu, Zhan Chao, Zhang YuBao. Significance of postoperative structural changes in serum N- glycans in pancreatic cancer patients[J]. Journal of Clinical Hepatology, 2014, 30(8): 749-751. doi: 10.3969/j.issn.1001-5256.2014.08.013

Supplements(0)

Cited By

Cited by
Periodical cited type(1)
1. 樊蕊蕊，高杰. 19例双表型肝细胞癌的临床病理分析. 诊断病理学杂志. 2025(03): 268-271+276 .
Other cited types(0)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(3) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (529) PDF downloads(35)

Value of multi-glycan in the auxiliary diagnosis of dual-phenotype hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2022.06.019

Abstract

References

Relative Articles

Cited by

Periodical cited type(1)

Other cited types(0)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Value of multi-glycan in the auxiliary diagnosis of dual-phenotype hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2022.06.019

Abstract

References

Relative Articles

Cited by

Periodical cited type(1)

Other cited types(0)

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content